Published online before print August 7, 2003, doi: 10.1161/01.ATV.0000090130.85752.ED
© 2003 American Heart Association, Inc.
Brief Reviews |
Arterial Smooth Muscle Cell Heterogeneity
Implications for Atherosclerosis and Restenosis Development
From the Department of Pathology, University of Geneva–CMU, Geneva, Switzerland.
Correspondence to Dr Marie-Luce Bochaton-Piallat, University of Geneva–CMU, Department of Pathology, 1 rue Michel-Servet, 1211 Geneva 4, Switzerland. E-mail Marie-Luce.Piallat{at}medecine.unige.ch
Series Editor:: Giulio Gabbiani
ATVB in Focus Smooth Muscle Cells
Previous Brief Reviews in this Series:
•Hillebrands J-L, Klatter FA, Rozing J. Origin of vascular smooth muscle cells and the role of circulating stem cells in transplant arteriosclerosis. 2003;23:380–387.
•Iso T, Hamamori Y, Kedes L. Notch signaling in vascular development. 2003;23:543–553.
•Kumar MS, Owens GK. Combinatorial control of smooth muscle-specific gene expression. 2003;23:737–747.
•Schaper W, Scholz D. Factors regulating arteriogenesis. 2003;23:1143–1151.
 |
Abstract |
|---|
 Top Abstract IntroductionEstablishment of Distinct SMC...Features of SMC SubpopulationsMarkers of Epithelioid and...Origin of Epithelioid and...Mechanisms of SMC Phenotypic...Conclusions and PerspectivesReferences |
|---|
During atheromatous plaque formation or restenosis after angioplasty, smooth muscle cells (SMCs) migrate from the media toward the intima, where they proliferate and undergo phenotypic changes. The mechanisms that regulate these phenomena and, in particular, the phenotypic modulation of intimal SMCs have been the subject of numerous studies and much debate during recent years. One view is that any SMCs present in the media could undergo phenotypic modulation. Alternatively, the seminal observation of Benditt and Benditt that human atheromatous plaques have the features of a monoclonal or an oligoclonal lesion has led to the hypothesis that a predisposed, medial SMC subpopulation could play a crucial role in the production of intimal thickening. The presence of a distinct SMC population in the arterial wall implies that under normal conditions, SMCs are phenotypically heterogeneous. The concept of SMC heterogeneity is gaining wider acceptance, as shown by the increasing number of publications on this subject. In this review, we discuss the in vitro studies that demonstrate the presence of distinct SMC subpopulations in arteries of various species, including humans. Their specific features and their regulation will be highlighted. Finally, the relevance of an atheroma-prone phenotype to intimal thickening formation will be discussed.
Key Words: smooth muscle cell • heterogeneity
|
Introduction |
|---|
|
TopAbstractIntroductionEstablishment of Distinct SMC...Features of SMC SubpopulationsMarkers of Epithelioid and...Origin of Epithelioid and...Mechanisms of SMC Phenotypic...Conclusions and PerspectivesReferences |
|---|
Smooth muscle cells (SMCs) are important actors in the pathogenesis of atherosclerosis and of restenosis after angioplasty or stent application. In both phenomena, one of the characteristic changes is the accumulation of SMCs within the intima. The contemporary paradigm is that the combined action of growth factors, proteolytic agents, and extracellular matrix proteins, produced by a dysfunctional endothelium and/or inflammatory cells, induces migration of SMCs from the media and their proliferation.1 Moreover, during these processes, SMCs switch from a contractile to a synthetic phenotype.2,3 Alternative to the predominant hypothesis that all SMCs of the media can undergo phenotypic modulation1 is the concept that a predisposed SMC subpopulation is responsible for the production of intimal thickening (IT). This possibility has been raised on the basis of original work by Benditt and Benditt,4 who reported that human atheromatous plaques have the features of a monoclonal lesion, an observation that has been confirmed by several laboratories.5–7 More recently, with use of in situ microdissection techniques, it has been demonstrated that human plaques are at least oligoclonal.8 These findings support the suggestion that SMCs of the arterial wall are biologically heterogeneous, and thus, attempts have been made to isolate distinct SMC phenotypes from arterial vessels. Intimal SMCs have been proposed to originate from diverse sources, including fibroblasts of the adventitia during restenosis,9 endothelial cells,10 and/or circulating bone marrow–derived cells.11 Although the existence of these possibilities is gaining acceptance, the role of each of them is subject to much debate. These possibilities, including the SMC origin of IT, are not mutually exclusive. The ultimate aim of these studies, including those that have investigated SMC heterogeneity, the focus of this review, is to define an atheroma-prone phenotype (APP) involved in atheroma and restenosis formation.
|
Establishment of Distinct SMC Populations |
|---|
|
TopAbstractIntroductionEstablishment of Distinct SMC...Features of SMC SubpopulationsMarkers of Epithelioid and...Origin of Epithelioid and...Mechanisms of SMC Phenotypic...Conclusions and PerspectivesReferences |
|---|
The concept of SMC heterogeneity has been established by the description of contractile and synthetic phenotypes in vivo and in vitro.2,3 The contractile phenotype is typical of the differentiated artery, and the synthetic one is typical of developing and pathologic arteries. A further step was the characterization in vitro of morphologically distinct SMC populations, which has been observed in many species, including humans (Table 1). Until now, the most-studied species has been the rat. The initial description of SMC heterogeneity was made in the rat carotid artery injury model, wherein 2 SMC populations were identified: (1) a spindle-shaped phenotype, with the classic "hill-and-valley" growth pattern, obtained from the normal media (NM), and (2) an epithelioid phenotype, in which cells grow as a monolayer and exhibit a cobblestone morphology at confluence, isolated from the IT 15 days after endothelial injury.12 This has been confirmed by many laboratories (Figure 1; eg, see Orlandi et al,13 Bochaton-Piallat et al,14 and Yan and Hansson15).
|
|
The last 2 decades have seen several advances in the understanding of SMC heterogeneity, including the identification of (1) distinct phenotypes in healthy arteries of the rat at different ages16–23; (2) SMC subpopulations from particular compartments within the NM of the rat aorta24; (3) clonal populations from the NM and IT of the rat aorta14,15,25,26; and (4) distinct phenotypes in arteries of various species, such as the dog,27 cow,28 pig,29 and human.30–32
SMC populations with either spindle-shaped or epithelioid phenotypes were isolated from the healthy rat aorta at different ages.18,19,21,22 In particular, spindle-shaped SMCs were predominant in fetuses at different developmental stages,22 as well as in newborn (4 to 5 days)19,21,33 and adult (6 weeks to 3 months) rats,13,21,34,35 whereas epithelioid SMCs were prevalent in old rats (>18 months).18,21 This suggests that the population of SMCs that exhibit an epithelioid phenotype in vitro increases in rat aortic NM with age. In this respect, several studies have shown that greater IT in response to injury is produced in old rats compared with adult rats.36–38 It is, however, noteworthy that a predominant population of epithelioid SMCs was recovered from the NM of 12-day-old newborn rats,16,17,20,23 an age when sexual maturation occurs. These results suggest that a proportion of SMCs that exhibit an epithelioid phenotype in vitro exists within the media throughout the whole life span and that its size can be influenced by circulating or microenvironmental factors.
Villaschi et al,24 using tissue explantation, isolated epithelioid SMCs from the luminal part of the rat aorta NM. Our group has produced clones from the NM and IT and has demonstrated that spindle-shaped and epithelioid clones can be recovered from both locations. However, the proportion of clones that exhibit these phenotypes differed according to their origin, the NM predominantly yielding spindle-shaped clones and the IT yielding a majority of epithelioid clones.14 Several groups have confirmed the production of SMC clones that exhibit spindle-shaped or epithelioid phenotypes from the NM of rats15,25,26 and mice.39 Taken together, these studies support the possibility that IT develops essentially from a distinct, medial subpopulation that exhibits an epithelioid phenotype when placed in culture. It should be noted that an SMC population that displays an epithelioid phenotype has been obtained from the NM of the spontaneously hypertensive rat aorta,40 extending the role of this subpopulation in arterial diseases other than atherosclerosis and demonstrating that SMCs with a propensity to produce an epithelioid population in culture can increase within the media subjected to pathologic stimuli.
Some experimental data indicate that rodent, including rat, SMCs are not ideal models for human SMCs (vide infra "Mechanisms of SMC Phenotypic Modulation"); hence, attempts have been made to culture SMCs from larger animals. Frid et al28,41 have performed extensive studies of bovine pulmonary artery and aorta. They first characterized the morphologically distinct compartments within the NM41 and then isolated from these compartments, by means of tissue explantation, SMC subpopulations that exhibited spindle-shaped, rhomboid, and epithelioid morphologies, the last 2 being similar to rat epithelioid SMCs.28 However, they did not study arterial lesions. In the canine carotid artery, Holifield et al27 have shown by sequential enzymatic digestion that spherical SMCs, similar to rat epithelioid cells, arise from the abluminal part of the NM and are predominant in the IT produced 14 days after endothelial injury. Our group has recently isolated 2 distinct SMC subpopulations from the porcine coronary artery.29 SMCs isolated by enzymatic digestion from the NM exhibit a spindle-shaped phenotype and grow in a hill-and-valley configuration,29,42 similar to SMCs derived from the porcine aortic NM.43,44 In contrast, SMCs obtained by tissue explantation are either spindle-shaped or rhomboid (flat, but more elongated than epithelioid rat SMCs); the luminal side of the media yields equal proportions of spindle-shaped and rhomboid SMCs, whereas the abluminal side yields a high proportion of rhomboid SMCs (Figure 1).29 With these same techniques, IT induced 15 days after stent implantation gives rise to a high proportion of rhomboid SMCs. Hence, these cells represent good candidates for the formation of IT in the porcine coronary artery.
Identification of particular SMC subpopulations in human arteries represents a difficult challenge for understandable reasons, such as material availability and experiment standardization. Nevertheless, distinct SMC subpopulations have been isolated from various human healthy and pathologic arteries.30,32,45–51 In the 1980s, Orekhov et al45,46 characterized the morphological polymorphism of SMCs isolated from arterial intima. Among the distinct shapes observed, elongated cells (ie, differentiated SMCs) were predominant in the unaffected intima, whereas stellate cells (ie, undifferentiated SMCs) were predominant in the atherosclerotic intima. Such increase was correlated with collagen deposition and lipid accumulation in the lesion.46 This cell diversity was partially retained in primary culture.47 At the same time, Björkerud48 showed that 2 cell types, distinguishable by their shape and adhesion properties, were present in SMCs cultured from IT. Taken together, these studies suggest the presence of phenotypically distinct SMC populations in human arteries. More recently, it was shown that SMC subpopulations isolated by tissue explantation49–51 or cell cloning30,32 from healthy30,32,49–51 or atherosclerotic49,51 arteries display phenotypic features similar to those observed in the rat and pig. In particular, the finding that epithelioid SMCs can be cloned from human arterial media32 supports the suggestion that expansion of an SMC subset in atherosclerotic lesions is conceivable. However, the relevance of SMC heterogeneity to human disease still remains to be demonstrated.
The distinct phenotypes of arterial SMCs have been mainly identified in vitro, suggesting that specific features of SMC subpopulations arise and are maintained because of the particular environment of cell culture. We have implanted into the rat carotid artery subjected to endothelial injury 2 SMC subpopulations, ie, spindle-shaped, isolated from newborn rats, and epithelioid, isolated from old rats, that exhibit distinct differentiation features (defined in addition to morphology by the expression level of 
-SM actin, SM myosin heavy chains [MHCs], and cellular retinol binding protein [CRBP]-1; vide infra "Features of SMC Subpopulations" and "Markers of Epithelioid and Spindle-Shaped Phenotypes").52 Once seeded, the 2 SMC populations maintained their distinct features, indicating that the phenotype of SMCs depends more on their intrinsic features rather than their environment, thereby reinforcing the notion of SMC heterogeneity.
|
Features of SMC Subpopulations |
|---|
|
TopAbstractIntroductionEstablishment of Distinct SMC...Features of SMC SubpopulationsMarkers of Epithelioid and...Origin of Epithelioid and...Mechanisms of SMC Phenotypic...Conclusions and PerspectivesReferences |
|---|
Irrespective of the species studied, epithelioid and rhomboid phenotypes, when compared with spindle-shaped SMCs, have in common several features, among which the most relevant are (1) enhanced proliferative activity, including serum-independent growth in some species; (2) enhanced migratory activity; (3) increased proteolytic activity; (4) poor level of differentiation, as defined by cytoskeletal and contractile protein expression (Table 2); and (5) high sensitivity to apoptotic stimuli.
|
In all species studied, epithelioid and rhomboid SMCs show a higher proliferative activity than do spindle-shaped SMCs; however, contrary to spindle-shaped SMCs, they stop growing at confluence as a result of cell contact inhibition.12,14,28,29,32 It is notable that rat epithelioid SMCs are able to grow in the absence of serum.13,14,16,18,20,23,53–55 In addition, albeit spindle-shaped, SMCs isolated from rat embryos exhibit serum-independent growth capacity.22 Epithelioid SMCs produce platelet-derived growth factor (PDGF)-BB, which is a potent SMC mitogen,16,20,23 and fail to respond to the growth-inhibitory effect of transforming growth factor (TGF)-ß.55 However, the factor(s) responsible for serum independence has never been clearly identified. Autonomous growth by epithelioid and rhomboid SMCs has been observed in other species,28,56 with the exception of the pig,29 which in this respect is similar to humans.32,51
One of the most striking differences between epithelioid or rhomboid and spindle-shaped SMCs is that the first exhibit a high migratory activity, as has been shown in the rat,14,57 pig,29 and humans.32 With the aim of exploring the mechanisms involved in this activity, we have demonstrated that rat epithelioid SMCs display high tissue plasminogen activator (tPA) activity58 and that pig rhomboid SMCs display high urokinase-type PA (uPA) activity.29 Likewise, Lau25 has shown that rat epithelioid SMCs might produce tPA, uPA, and metalloproteinase-2 under particular growth conditions. In this respect, both PAs have been detected in both experimental IT59–61 and human atherosclerotic62–65 lesions.
The study of cytoskeletal proteins, which are accepted as reliable differentiation markers,66–70 has allowed characterization of the contractile versus the synthetic phenotype (Table 2). It should be noted that when placed in culture, all SMCs tend to show a dedifferentiated phenotype.2,3 With this limitation, the phenotypic variation of cultured SMCs furnishes important information concerning the influence of many factors on their biologic features. -SM actin is expressed in vascular SMCs,71 even at early stages of development, and thus represents the most general marker of SMC lineage.72 Although -SM actin is permanently expressed in SMCs, it is more abundant in spindle-shaped SMCs than in epithelioid or rhomboid SMCs.14,21,23,27–29,32,33,57 Desmin, an intermediate filament protein, and SMMHC are expressed in well-differentiated SMCs70,72 and are relatively well studied. In cultured rat SMCs, desmin generally disappears.35 In larger animals, desmin is maintained at a significant level of expression in spindle-shaped SMCs, whereas it is hardly detectable in epithelioid and rhomboid SMCs.28,29 SMMHCs are clearly expressed more importantly in spindle-shaped SMCs than in epithelioid and rhomboid SMCs.14,21,23,28,29,33,57 Other cytoskeletal proteins have been less extensively studied. In particular, smoothelin, SM22, calponin, h-caldesmon, and metavinculin70 serve as late differentiation makers and are more abundant in spindle-shaped SMCs than in epithelioid and rhomboid SMCs.27–29,56 In general, SMCs isolated from larger animals, including humans, are more differentiated than are those isolated from rodents. Porcine spindle-shaped SMCs maintain appreciable expression of -SM actin, SMMHC, desmin, and smoothelin.29,42 SMMHC, calponin, h-caldesmon, and metavinculin are abundantly expressed in bovine spindle-shaped SMCs.28 SMCs isolated from human arteries behave similarly.32 An interesting correlation has been demonstrated, albeit occasionally, between dedifferentiated and/or highly proliferating SMC phenotypes and increased LDL uptake50,73–75 or decreased HDL binding sites.76 The role of LDL and HDL processes in atheromatous plaque formation with respect to SMC heterogeneity should be further investigated. Taken together, the data obtained in different species suggest that the degree of differentiation of SMCs changes with the phenotype; this integrates well into a view that reconciles the heterogeneity of SMCs with the modulation concepts.
An enhanced susceptibility of rat epithelioid SMCs to apoptosis induced by reactive oxygen species,26 retinoic acid, and antimitotic drugs77 has been recently described. Interestingly, SMCs isolated from healthy human coronary arteries show marked heterogeneity to Fas-induced apoptosis.78 It is noteworthy that apoptosis is an important phenomenon in the development of experimental IT and has been detected in SMCs of atherosclerotic and restenotic lesions (for a review of different aspects of this problem, see Kockx and Herman,79 McCarthy and Bennett,80 and Geng and Libby81). Apoptosis could participate in the regulation of cellularity in restenosis and in the stability of the plaque; the role of distinct SMC populations in this context remains to be demonstrated.
|
Markers of Epithelioid and Spindle-Shaped Phenotypes |
|---|
|
TopAbstractIntroductionEstablishment of Distinct SMC...Features of SMC SubpopulationsMarkers of Epithelioid and...Origin of Epithelioid and...Mechanisms of SMC Phenotypic...Conclusions and PerspectivesReferences |
|---|
Once distinct populations have been defined, the ultimate aim is to identify genes and/or proteins that are differentially expressed and to test whether they are involved in the phenotypic changes that occur in vivo. Using the technique of 2-dimensional polyacrylamide gel electrophoresis, we have identified several proteins that are differentially expressed in rat aortic spindle-shaped versus epithelioid SMCs.82,83 Among them, 3 proteins have been sequenced and identified as markers of the rat epithelioid phenotype in vitro: CRBP-1, a protein involved in retinoid metabolism, and cytokeratins 8 and 18, intermediate filament proteins.
In vivo, CRBP-1 is constitutively expressed in rare SMCs of the NM of adult and old rats but not of newborn rats.83 After endothelial injury, CRBP-1 is rapidly activated in a subset of medial SMCs located toward the lumen and is expressed in the large majority of SMCs present in the IT; however, it disappears when reendothelialization is achieved. Remodeling of IT is associated with SMC apoptosis.84–86 CRBP-1, which is present in replicative SMCs during the initial phase of IT formation, is also detected in apoptotic cells of IT.83 Altogether, these results suggest that a predisposed subset of medial SMCs becomes rapidly CRBP-1–positive after injury, undergoes replication during the early phase of IT development, and then disappears, allegedly through apoptosis, when reendothelialization takes place.83 Some additional data support this scenario: SMCs cultured from reendothelialized IT (60 days after injury) are exclusively spindle-shaped, suggesting that potentially epithelioid SMCs have disappeared.13 Moreover, cultured rat epithelioid SMCs are more sensitive to apoptosis than are spindle-shaped SMCs.26,77 Taken together, these results indicate that CRBP-1 is a marker of the epithelioid phenotype in vitro and of SMC activation after endothelial injury in vivo. Unfortunately, when the analysis of CRBP-1 expression was extended to pigs and humans in vitro and in vivo, the role of this protein as a marker was not confirmed (M.-L. Bochaton-Piallat, P. Neuville, G. Gabbiani, unpublished observations). This further supports the assumption that rodent SMCs do not represent a reliable model for human SMCs.
Cytokeratins 8 and 18, intermediate filament proteins, as well as zonula occludens-2 protein and cingulin, 2 proteins of tight junctions, were thought to be exclusively expressed in epithelial or endothelial cells. They have since been identified as markers of rodent epithelioid SMCs39,83,87 and are expressed in experimental IT87 or human atheromatous plaque.88 Studies of these proteins could give further insight into the mechanisms of SMC pathologic modulation.
Several other genes have been discovered, mainly in rodents, as being specific or at least more abundant in 1 SMC population compared with the other. Epithelioid SMCs express osteopontin,89–92 tropoelastin,20,23,87 PDGF-BB,20,23 cytochrome P450,93 and peroxisome proliferator-activated receptor-
,87 whereas spindle-shaped SMCs express procollagen type I and PDGF- receptor.20,23,87 This pattern of gene expression is broadly observed in cloned SMCs that exhibit phenotypes similar to their parental populations, with the exception of procollagen type I, whose expression appears to be sensitive to cell density and serum level.23 Although none of these genes has conclusively been proved to be relevant to the pathogenesis of human lesions, the study of osteopontin, an extracellular matrix protein involved in bone mineralization, has shed new light on the mechanisms of IT formation. Osteopontin is associated with SMC proliferation90 and migration.94,95 In vivo, it is transiently upregulated in experimental IT91,96 and accumulates in calcified areas of the atheromatous plaque.91,97–99 Recently, it has been shown that SMCs lose their lineage markers and acquire an osteogenic phenotype in vitro under calcifying conditions and in vivo in transgenic mice whose arteries calcify spontaneously.100 This suggests that SMCs can play a role in vascular calcification.
Interestingly, the subtractive hybridization approach with RNA isolated from rat embryo SMCs with an autonomous growth property and rat adult SMCs with a nonautonomous growth property22 allowed identification of several embryonic genes; one of them, ie, embryonic growth-associated protein, is involved in the serum-independent growth of embryonic SMCs and is reexpressed in experimentally induced IT.101
Recent studies performed in species other than the rat are providing novel insight into the understanding of IT formation. Autonomously growing, rhomboid SMCs isolated from bovine pulmonary artery exhibited constitutively activated extracellular signal–regulated kinase (ERK-2) and eicosanoid production.102 Other studies with microarray techniques or differential-display polymerase chain reaction have been performed with SMCs in various situations, yielding identification of numerous, differentially expressed genes in monkeys and humans.103–105 They are either unknown or known to be involved in atherosclerotic processes. A very recent study with suppressive subtractive hybridization that was performed in the pig has compared the coronary artery, predisposed to atherosclerosis, with the mammary artery, which is resistant to atherosclerosis.106 Genes that are preferentially associated with the mammary artery are involved in cell-cell junction formation, whereas genes that are preferentially expressed in the coronary artery are implicated in lipid metabolism, inflammation, and cell proliferation. However, the presence of distinct SMC populations within the same vessel has not been taken into account in these studies.
Taken together, the studies performed in a variety of species, including humans, provide evidence that arterial SMCs are phenotypically heterogeneous. Moreover, the epithelioid and rhomboid (according to the species) phenotypes are good candidates for representing the APP for several reasons: (1) they always exhibit an enhanced capacity for proliferation and migration that is associated with high proteolytic activity, features essential for the accumulation of SMCs in the IT; (2) they acquire a poorly differentiated phenotype typical of intimal SMCs in vivo; and (3) they express specific proteins crucial for their behavior. In this respect, the most demonstrative example is the identification of CRBP-1 as a specific marker of intimal SMCs in the rat model. The discovery of new genes and/or proteins typical of the APP in other species is still a challenge and, once possible, should provide new insight into the understanding of atherosclerosis and restenosis mechanisms.
|
Origin of Epithelioid and Spindle- Shaped Phenotypes |
|---|
|
TopAbstractIntroductionEstablishment of Distinct SMC...Features of SMC SubpopulationsMarkers of Epithelioid and...Origin of Epithelioid and...Mechanisms of SMC Phenotypic...Conclusions and PerspectivesReferences |
|---|
During vasculogenesis, SMCs have been proved to originate from diverse sources depending on the vessel type: mesoderm, neurectoderm (neural crest), epicardium (for coronary arteries), and, more rarely, endothelium.10 This has led to the hypothesis that the various SMC phenotypes could arise from distinct lineages. A study performed in the chick embryo aorta has shown that spindle-shaped and epithelioid phenotypes can be isolated from 2 distinct regions of the artery, which differ in their embryologic origin, namely, the mesoderm and neural crest.56 The 2 populations are quite similar in their cytoskeletal equipment but respond differently to TGF-ß. These results suggest that different SMC subpopulations play a role in the formation of the tunica media, at least in the chick embryo.
The morphological similarity of epithelioid SMCs to endothelial cells has led Kohler et al107 to investigate whether this SMC subtype exhibits an angiogenic capacity. For this purpose, they cultured mouse epithelioid SMCs in a collagen gel and observed that they were capable of forming vessel-like structures, and in coculture, that they induced spindle-shaped SMCs to participate in this process. Moreover, Nicosia and Villaschi108 have shown that the luminal part of the rat aorta, which contains predominantly epithelioid SMCs (vide supra "Establishment of Distinct SMC Populations"), gives rise to pericytes when placed in coculture with endothelial cell–forming microvessels, whereas SMCs from the deeper part of the aorta (mainly composed of spindle-shaped SMCs) do not. We have shown that the capacity of porcine rhomboid SMCs to invade a collagen gel is remarkably higher than that of spindle-shaped SMCs.29 These data suggest that epithelioid SMCs could play a major role in angiogenesis and/or arteriogenesis.109 In addition, they could be considered a potential source of locally derived stem cells, ie, cells present in adult tissues that exhibit pluripotent features.110
Recent studies suggest that endothelial cells could acquire SMC features, ie, -SM actin expression in vitro111 and in vivo.10 Moreover, bone marrow–derived cells have been reported to undergo transdifferentiation toward the SMC phenotype in transplant arteriopathy,112,113 in IT induced after arterial injury,113,114 and in hypercholesterolemia-induced IT.115 Although considered a minor source of SMCs, it would be of interest to study whether these cells participate in the emergence of those that exhibit the APP.
|
Mechanisms of SMC Phenotypic Modulation |
|---|
|
TopAbstractIntroductionEstablishment of Distinct SMC...Features of SMC SubpopulationsMarkers of Epithelioid and...Origin of Epithelioid and...Mechanisms of SMC Phenotypic...Conclusions and PerspectivesReferences |
|---|
Many attempts have been made to modulate the behavior of distinct SMC subpopulations. The factors tested can be distributed in 4 categories: (1) those described as classic inhibitors of SMC proliferation and/or increasing SMC differentiation, eg, heparin, TGF-ß, and retinoic acid; (2) those known to stimulate SMC proliferation and/or decrease SMC differentiation, eg, PDGF-BB, fibroblast growth factor (FGF)-2, and insulin growth factor-I and II; (3) vasoactive substances, such as endothelin-1, angiotensin II, histamine, and norepinephrine; and finally (4) vasodilator factors, such as nitric oxide (NO).
Heparin, which is the most powerful inhibitor of SMC growth in vitro and in vivo, at least in the rat,116,117 did not exhibit differences of action on the distinct rat118 or pig29 SMC subpopulations. In the bovine pulmonary artery model, heparin exerted dramatic growth inhibition on rhomboid SMCs, whereas it had almost no effect on spindle-shaped SMCs.28 These results indicate that the action of heparin on diverse SMC subpopulations depends on the species studied.
In the rat, TGF-ß118 as well as retinoic acid119 changes the morphology of epithelioid SMCs; however, these cells do not achieve a typical spindle-shaped phenotype. In contrast, in pig coronary artery SMCs, TGF-ß does not influence SMC morphology, although it does decrease proliferation and increase the differentiation level of both SMC subtypes. In the rat, retinoic acid increases the expression of -SM actin only in epithelioid but not in spindle-shaped SMCs; however, in both cell types, retinoic acid decreases proliferation and increases migration.119 All of the effects of retinoic acid are mediated by the nuclear receptor RAR-. These results indicate that rat epithelioid SMCs, ie, CRBP-1–positive SMCs, are more prone to respond to retinoic acid than are spindle-shaped SMCs, at least so far as their differentiation state is concerned. In vivo, feeding rats with retinoic acid or with an RAR- agonist inhibits aortic or carotid artery IT formation,119–121 thus functionally confirming that CRBP-1 is a marker of the APP in the rat model.
Some articles have shown that spindle-shaped SMCs are more responsive than are epithelioid SMCs to vasoactive factors such as endothelin-1,24 angiotensin II, histamine, and norepinephrine,32 either by measuring collagen gel contraction or by evaluating the intracellular calcium concentration. This is in accordance with the contractile feature of spindle-shaped SMCs. Conversely, epithelioid SMCs exhibit increased expression of inducible NO synthase,15,122 which is correlated with enhanced nuclear factor-
B expression when compared with spindle-shaped SMCs.122 Moreover, these cells fail to respond to NO15,38 because of the lack of the ß-subunit of soluble guanylyl cyclase.38 This suggests that despite a large production of NO, epithelioid SMCs are less sensitive than are spindle-shaped SMCs to NO actions.
FGF-2 and PDGF-BB similarly increase the proliferation and migration of porcine SMC subpopulations.29 Human epithelioid SMCs migrate more actively than do spindle-shaped SMCs in response to PFGF-BB.32 We have shown that FGF-2 and PDGF-BB induce a switch from the spindle-shaped to the rhomboid phenotype in pig SMCs.29 This is associated with increased proliferation and a decrease in expression of differentiation markers. A similar effect has been obtained for spindle-shaped SMC clones. In both situations, this shape change is reversible when treatment is ceased. These results indicate that the switch depends on phenotypic modulation rather than on selection of a given population. Interestingly, endothelial cells isolated from the porcine coronary artery and placed in coculture with SMCs induce a switch from the spindle-shaped to the rhomboid phenotype.29 In these experiments, endothelial cells did not exhibit a quiescent state even after confluence, suggesting that they mimic an injured or dysfunctional endothelium. In other species, previous studies with endothelial cell/SMC cocultures have shown that endothelial cells stimulate SMC proliferation123–125 and decrease the expression of -SM actin and SMMHC,126 particularly when nonquiescent endothelial cells are used. It has been suggested that endothelial cells stimulate the proliferation of SMCs by producing plasminogen activator inhibitor-1, which in turn inhibits TGF-ß activation.124,127,128 The mechanisms through which endothelial cells specifically act on porcine spindle-shaped SMCs remain to be clarified, but these results indicate that spindle-shaped SMCs can evolve, at least to some extent, into the rhomboid phenotype, supporting the view that pig SMCs display an enhanced phenotypic plasticity compared with rat SMCs. It will be important to establish whether this plasticity is present in human SMCs.
|
Conclusions and Perspectives |
|---|
|
TopAbstractIntroductionEstablishment of Distinct SMC...Features of SMC SubpopulationsMarkers of Epithelioid and...Origin of Epithelioid and...Mechanisms of SMC Phenotypic...Conclusions and PerspectivesReferences |
|---|
The original observation by Benditt and Benditt4 has stimulated a significant number of experiments, which support the possibility that SMC heterogeneity exists in different species. Epithelioid and/or rhomboid SMCs appear to be the most likely candidate to represent the APP by playing an important role in the formation of IT.
Studies on the possibility that an SMC phenotype can evolve into another have shown that the results depend on the species used. This suggests that the mechanisms of IT formation differ according to the model (Figure 2). Thus, in the rat, the most studied model, SMCs show 2 phenotypes that do not appear to be interchangeable, both in vitro and in vivo. Indeed, the specific phenotype of SMC observed in vitro is maintained when they are placed back into an in vivo environment. The evolution of the lesion in vivo appears to depend on the relative replicative activity and/or susceptibility to apoptosis of these phenotypes. Moreover, in the rat, an agent that influences the biologic behavior of epithelioid SMCs, ie, retinoic acid, inhibits IT formation. In the pig, the situation is different, in that spindle-shaped SMCs can modulate into rhomboid SMCs and, if the stimulus ceases, can return to their original phenotype, at least in vitro. This supports the assumption that the evolution of in vivo lesions is more complex in the pig than in the rat. In this respect, porcine SMCs appear to behave similarly to human SMCs.
|
) or first express CRBP-1 in the media before migrating toward the intima (
). It should be noted that the non–AP-SMCs (ie, spindle-shaped phenotype) and AP-SMCs (epithelioid phenotype) are not interchangeable. In the porcine model, AP-SMCs are located at the abluminal part of the media. The mechanisms (
). For a dynamic view, see video available at http://atvb.ahajournals.org.It should be emphasized that at present, the phenotypic identification of APP SMCs other than in the rat is at a very early stage. Studies at the genetic and/or proteomic levels similar to those performed in the rat are needed to achieve clear identification of the markers of each phenotype in vitro and in vivo. An extension of these studies to vascular development in appropriate species will also furnish useful information on the origin of different SMC phenotypes and on their localization in arterial vessels. In conclusion, the paradigm of SMC heterogeneity has begun to produce experimental information and should be very useful in the future to characterize precisely the biologic features of arterial SMCs and to yield a better understanding of the role of different SMC subpopulations in physiologic and pathologic situations.
|
Acknowledgments |
|---|
The authors acknowledge the support of the Swiss National Science Foundation (grant Nos. 31.061336.00 and 32–068034.02). We thank Pierre-Alain Rüttimann and Jean-Claude Rumbeli for their graphic work.
Received May 14, 2003; accepted June 16, 2003.
|
References |
|---|
|
TopAbstractIntroductionEstablishment of Distinct SMC...Features of SMC SubpopulationsMarkers of Epithelioid and...Origin of Epithelioid and...Mechanisms of SMC Phenotypic...Conclusions and PerspectivesReferences |
|---|
1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340: 115–126.
2. Campbell G, Campbell J. The phenotypes of smooth muscle expressed in human atheroma. Ann N Y Acad Sci. 1990; 598: 143–158.[Medline] [Order article via Infotrieve]
3. Thyberg J, Blomgren K, Hedin U, Dryjski M. Phenotypic modulation of smooth muscle cells during the formation of neointimal thickenings in the rat carotid artery after balloon injury: an electron-microscopic and stereological study. Cell Tissue Res. 1995; 281: 421–433.[Medline] [Order article via Infotrieve]
4. Benditt EP, Benditt JM. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci U S A. 1973; 70: 1753–1756.
5. Pearson TA, Dillman JM, Solez K, Heptinstall RH. Clonal characteristics in layers of human atherosclerotic plaques: a study of the selection hypothesis of monoclonality. Am J Pathol. 1978; 93: 93–116.[Abstract]
6. Pearson TA, Dillman JM, Solez K, Heptinstall RH. Clonal markers in the study of the origin and growth of human atherosclerotic lesions. Circ Res. 1978; 43: 10–18.
7. Thomas WA, Kim DN. Biology of disease: atherosclerosis as a hyperplastic and/or neoplastic process. Lab Invest. 1983; 48: 245–255.[Medline] [Order article via Infotrieve]
8. Schwartz SM, Murry CE. Proliferation and the monoclonal origins of atherosclerotic lesions. Annu Rev Med. 1998; 49: 437–460.[CrossRef][Medline] [Order article via Infotrieve]
9. Zalewski A, Shi Y, Johnson AG. Diverse origin of intimal cells: smooth muscle cells, myofibroblasts, fibroblasts, and beyond? Circ Res. 2002; 91: 652–655.
10. Gittenberger-de Groot AC, DeRuiter MC, Bergwerff M, Poelmann RE. Smooth muscle cell origin and its relation to heterogeneity in development and disease. Arterioscler Thromb Vasc Biol. 1999; 19: 1589–1594.
11. Hillebrands JL, Klatter FA, Rozing J. Origin of vascular smooth muscle cells and the role of circulating stem cells in transplant arteriosclerosis. Arterioscler Thromb Vasc Biol. 2003; 23: 380–387.
12. Walker LN, Bowen-Pope DF, Ross R, Reidy MA. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci U S A. 1986; 83: 7311–7315.
13. Orlandi A, Ehrlich HP, Ropraz P, Spagnoli LG, Gabbiani G. Rat aortic smooth muscle cells isolated from different layers and at different times after endothelial denudation show distinct biological features in vitro. Arterioscler Thromb Vasc Biol. 1994; 14: 982–989.
14. Bochaton-Piallat ML, Ropraz P, Gabbiani F, Gabbiani G. Phenotypic heterogeneity of rat arterial smooth muscle cell clones: implications for the development of experimental intimal thickening. Arterioscler Thromb Vasc Biol. 1996; 16: 815–820.
15. Yan ZQ, Hansson GK. Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ Res. 1998; 82: 21–29.
16. Seifert RA, Schwartz SM, Bowen-Pope DF. Developmentally regulated production of platelet-derived growth factor-like molecules. Nature. 1984; 311: 669–671.[CrossRef][Medline] [Order article via Infotrieve]
17. Gordon D, Mohai LG, Schwartz SM. Induction of polyploidy in cultures of neonatal rat aortic smooth muscle cells. Circ Res. 1986; 59: 633–644.
18. McCaffrey TA, Nicholson AC, Szabo PE, Weksler ME, Weksler BB. Aging and arteriosclerosis: the increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth factor-like activity. J Exp Med. 1988; 167: 163–174.
19. Hültgardh-Nilsson A, Krondahl U, Querol-Ferrer V, Ringertz NR. Differences in growth factor response in smooth muscle cells isolated from adult and neonatal rat arteries. Differentiation. 1991; 47: 99–105.[CrossRef][Medline] [Order article via Infotrieve]
20. Majesky MW, Giachelli CM, Reidy MA, Schwartz SM. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. Circ Res. 1992; 71: 759–768.
21. Bochaton-Piallat ML, Gabbiani F, Ropraz P, Gabbiani G. Age influences the replicative activity and the differentiation features of cultured rat aortic smooth muscle cell populations and clones. Arterioscler Thromb Vasc Biol. 1993; 13: 1449–1455.
22. Cook CL, Weiser MC, Schwartz PE, Jones CL, Majack RA. Developmentally timed expression of an embryonic growth phenotype in vascular smooth muscle cells. Circ Res. 1994; 74: 189–196.
23. Lemire JM, Covin CW, White S, Giachelli CM, Schwartz SM. Characterization of cloned aortic smooth muscle cells from young rats. Am J Pathol. 1994; 144: 1068–1081.[Abstract]
24. Villaschi S, Nicosia RF, Smith MR. Isolation of a morphologically and functionally distinct smooth muscle cell type from the intimal aspect of the normal rat aorta; evidence for smooth muscle cell heterogeneity. In Vitro Cell Dev Biol Anim. 1994; 30A: 589–595.[CrossRef]
25. Lau HK. Regulation of proteolytic enzymes and inhibitors in two smooth muscle cell phenotypes. Cardiovasc Res. 1999; 43: 1049–1059.
26. Li WG, Miller FJ Jr, Brown MR, Chatterjee P, Aylsworth GR, Shao J, Spector AA, Oberley LW, Weintraub NL. Enhanced H2O2-induced cytotoxicity in ‘epithelioid’ smooth muscle cells: implications for neointimal regression. Arterioscler Thromb Vasc Biol. 2000; 20: 1473–1479.
27. Holifield B, Helgason T, Jemelka S, Taylor A, Navran S, Allen J, Seidel C. Differentiated vascular myocytes: are they involved in neointimal formation? J Clin Invest. 1996; 97: 814–825.[Medline] [Order article via Infotrieve]
28. Frid MG, Aldashev AA, Dempsey EC, Stenmark KR. Smooth muscle cells isolated from discrete compartments of the mature vascular media exhibit unique phenotypes and distinct growth capabilities. Circ Res. 1997; 81: 940–952.
29. Hao H, Ropraz P, Verin V, Camenzind E, Geinoz A, Pepper MS, Gabbiani G, Bochaton-Piallat ML. Heterogeneity of smooth muscle cell populations cultured from pig coronary artery. Arterioscler Thromb Vasc Biol. 2002; 22: 1093–1099.
30. Benzakour O, Kanthou C, Kanse SM, Scully MF, Kakkar VV, Cooper DN. Evidence for cultured human vascular smooth muscle cell heterogeneity: isolation of clonal cells and study of their growth characteristics. Thromb Haemost. 1996; 75: 854–858.[Medline] [Order article via Infotrieve]
31. Li S, Sims S, Jiao Y, Chow LH, Pickering JG. Evidence from a novel human cell clone that adult vascular smooth muscle cells can convert reversibly between noncontractile and contractile phenotypes. Circ Res. 1999; 85: 338–348.
32. Li S, Fan YS, Chow LH, Van Den Diepstraten C, van Der Veer E, Sims SM, Pickering JG. Innate diversity of adult human arterial smooth muscle cells: cloning of distinct subtypes from the internal thoracic artery. Circ Res. 2001; 89: 517–525.
33. Bochaton-Piallat ML, Gabbiani F, Ropraz P, Gabbiani G. Cultured aortic smooth muscle cells from newborn and adult rats show distinct cytoskeletal features. Differentiation. 1992; 49: 175–185.[Medline] [Order article via Infotrieve]
34. Haudenschild CC, Grünwald J. Proliferative heterogeneity of vascular smooth muscle cells and its alteration by injury. Exp Cell Res. 1985; 157: 364–370.[CrossRef][Medline] [Order article via Infotrieve]
35. Skalli O, Bloom WS, Ropraz P, Azzarone B, Gabbiani G. Cytoskeletal remodeling of rat aortic smooth muscle cells in vitro: relationships to culture conditions and analogies to in vivo situations. J Submicrosc Cytol Pathol. 1986; 18: 481–493.
36. Hariri RJ, Alonso DR, Hajjar DP, Coletti D, Weksler ME. Aging and arteriosclerosis, I: development of myointimal hyperplasia after endothelial injury. J Exp Med. 1986; 164: 1171–1178.
37. Stemerman MB, Weinstein R, Rowe JW, Maciag T, Fuhro R, Gardner R. Vascular smooth muscle cell growth kinetics in vivo in aged rats. Proc Natl Acad Sci U S A. 1982; 79: 3863–3866.
38. Chen L, Daum G, Fischer JW, Hawkins S, Bochaton-Piallat ML, Gabbiani G, Clowes AW. Loss of expression of the ß-subunit of soluble guanylyl cyclase prevents nitric oxide–mediated inhibition of DNA synthesis in smooth muscle cells of old rats. Circ Res. 2000; 86: 520–525.
39. Ehler E, Jat PS, Noble MD, Citi S, Draeger A. Vascular smooth muscle cells of H-2Kb-tsA58 transgenic mice: characterization of cell lines with distinct properties. Circulation. 1995; 92: 3289–3296.
40. Hall KL, Harding JW, Hosick HL. Isolation and characterization of clonal vascular smooth muscle cell lines from spontaneously hypertensive and normotensive rat aortas. In Vitro Cell Dev Biol. 1991; 27: 791–798.[CrossRef]
41. Frid MG, Moiseeva EP, Stenmark KR. Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial media in vivo. Circ Res. 1994; 75: 669–681.
42. Christen T, Bochaton-Piallat ML, Neuville P, Rensen S, Redard M, van Eys G, Gabbiani G. Cultured porcine coronary artery smooth muscle cells: a new model with advanced differentiation. Circ Res. 1999; 85: 99–107.
43. Chamley-Campbell JH, Campbell GR, Ross R. Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens. J Cell Biol. 1981; 89: 379–383.
44. Patel S, Shi Y, Niculescu R, Chung EH, Martin JL, Zalewski A. Characteristics of coronary smooth muscle cells and adventitial fibroblasts. Circulation. 2000; 101: 524–532.
45. Orekhov AN, Karpova II, Tertov VV, Rudchenko SA, Andreeva ER, Krushinsky AV, Smirnov VN. Cellular composition of atherosclerotic and uninvolved human aortic subendothelial intima: light-microscopic study of dissociated aortic cells. Am J Pathol. 1984; 115: 17–24.[Abstract]
46. Orekhov AN, Andreeva ER, Krushinsky AV, Novikov ID, Tertov VV, Nestaiko GV, Khashimov KhA, Repin VS, Smirnov VN. Intimal cells and atherosclerosis: relationship between the number of intimal cells and major manifestations of atherosclerosis in the human aorta. Am J Pathol. 1986; 125: 402–415.[Abstract]
47. Orekhov AN, Krushinsky AV, Andreeva ER, Repin VS, Smirnov VN. Adult human aortic cells in primary culture: heterogeneity in shape. Heart Vessels. 1986; 2: 193–201.[CrossRef][Medline] [Order article via Infotrieve]
48. Björkerud S. Cultivated human arterial smooth muscle displays heterogeneous pattern of growth and phenotypic variation. Lab Invest. 1985; 53: 303–310.[Medline] [Order article via Infotrieve]
49. Bonin LR, Madden K, Shera K, Ihle J, Matthews C, Aziz S, Perez-Reyes N, McDougall JK, Conroy SC. Generation and characterization of human smooth muscle cell lines derived from atherosclerotic plaque. Arterioscler Thromb Vasc Biol. 1999; 19: 575–587.
50. Llorente-Cortes V, Martinez-Gonzalez J, Badimon L. Differential cholesteryl ester accumulation in two human vascular smooth muscle cell subpopulations exposed to aggregated LDL: effect of PDGF-stimulation and HMG-CoA reductase inhibition. Atherosclerosis. 1999; 144: 335–342.[CrossRef][Medline] [Order article via Infotrieve]
51. Martinez-Gonzalez J, Berrozpe M, Varela O, Badimon L. Heterogeneity of smooth muscle cells in advanced human atherosclerotic plaques: intimal smooth muscle cells expressing a fibroblast surface protein are highly activated by platelet-released products. Eur J Clin Invest. 2001; 31: 939–949.[CrossRef][Medline] [Order article via Infotrieve]
52. Bochaton-Piallat ML, Clowes AW, Clowes MM, Fischer JW, Redard M, Gabbiani F, Gabbiani G. Cultured arterial smooth muscle cells maintain distinct phenotypes when implanted into carotid artery. Arterioscler Thromb Vasc Biol. 2001; 21: 949–954.
53. Grünwald J, Haudenschild CC. Intimal injury in vivo activates vascular smooth muscle cell migration and explant outgrowth in vitro. Arteriosclerosis. 1984; 4: 183–188.
54. Schwartz SM, Foy L, Bowen-Pope DF, Ross R. Derivation and properties of platelet-derived growth factor-independent rat smooth muscle cells. Am J Pathol. 1990; 136: 1417–1428.[Abstract]
55. McCaffrey TA, Falcone DJ. Evidence for an age-related dysfunction in the antiproliferative response to transforming growth factor-ß in vascular smooth muscle cells. Mol Biol Cell. 1993; 4: 315–322.[Abstract]
56. Topouzis S, Majesky MW. Smooth muscle lineage diversity in the chick embryo: two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-ß. Dev Biol. 1996; 178: 430–445.
57. Li Z, Cheng H, Lederer WJ, Froehlich J, Lakatta EG. Enhanced proliferation and migration and altered cytoskeletal proteins in early passage smooth muscle cells from young and old rat aortic explants. Exp Mol Pathol. 1997; 64: 1–11.[CrossRef][Medline] [Order article via Infotrieve]
58. Bochaton-Piallat M-L, Gabbiani G, Pepper MS. Plasminogen activator expression in rat arterial smooth muscle cells depends on their phenotype and is modulated by cytokines. Circ Res. 1998; 82: 1086–1093.
59. Clowes AW, Clowes MM, Au YP, Reidy MA, Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res. 1990; 67: 61–67.
60. Reidy MA, Irvin C, Lindner V. Migration of arterial wall cells: expression of plasminogen activators and inhibitors in injured rat arteries. Circ Res. 1996; 78: 405–414.
61. Carmeliet P, Moons L, Herbert JM, Crawley J, Lupu F, Lijnen R, Collen D. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. Circ Res. 1997; 81: 829–839.
62. Lupu F, Heim DA, Bachmann F, Hurni M, Kakkar VV, Kruithof EK. Plasminogen activator expression in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 1995; 15: 1444–1455.
63. Noda-Heiny H, Daugherty A, Sobel BE. Augmented urokinase receptor expression in atheroma. Arterioscler Thromb Vasc Biol. 1995; 15: 37–43.
64. Raghunath PN, Tomaszewski JE, Brady ST, Caron RJ, Okada SS, Barnathan ES. Plasminogen activator system in human coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 1995; 15: 1432–1443.
65. Steins MB, Padro T, Li CX, Mesters RM, Ostermann H, Hammel D, Scheld HH, Berdel WE, Kienast J. Overexpression of tissue-type plasminogen activator in atherosclerotic human coronary arteries. Atherosclerosis. 1999; 145: 173–180.[CrossRef][Medline] [Order article via Infotrieve]
66. Kocher O, Gabbiani G. Cytoskeletal features of normal and atheromatous human arterial smooth muscle cells. Hum Pathol. 1986; 17: 875–880.[Medline] [Order article via Infotrieve]
67. Schwartz SM, deBlois D, O’Brien ER. The intima: soil for atherosclerosis and restenosis. Circ Res. 1995; 77: 445–465.
68. Shanahan CM, Weissberg PL. Smooth muscle cell heterogeneity: patterns of gene expression in vascular smooth muscle cells in vitro and in vivo. Arterioscler Thromb Vasc Biol. 1998; 18: 333–338.
69. Owens GK. Molecular control of vascular smooth muscle cell differentiation. Acta Physiol Scand. 1998; 164: 623–635.[Medline] [Order article via Infotrieve]
70. Sartore S, Franch R, Roelofs M, Chiavegato A. Molecular and cellular phenotypes and their regulation in smooth muscle. Rev Physiol Biochem Pharmacol. 1999; 134: 235–320.[Medline] [Order article via Infotrieve]
71. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against -smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol. 1986; 103: 2787–2796.
72. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 1995; 75: 487–517.
73. Campbell JH, Reardon MF, Campbell GR, Nestel PJ. Metabolism of atherogenic lipoproteins by smooth muscle cells of different phenotype in culture. Arteriosclerosis. 1985; 5: 318–328.
74. Parlavecchia M, Skalli O, Gabbiani G. LDL accumulation in cultured rat aortic smooth muscle cells with different cytoskeletal phenotypes. J Vasc Med Biol. 1989; 1: 308–313.
75. Thyberg J. Caveolae and cholesterol distribution in vascular smooth muscle cells of different phenotypes. J Histochem Cytochem. 2002; 50: 185–195.
76. Dusserre E, Bourdillon MC, Pulcini T, Berthezene F. Decrease in high density lipoprotein binding sites is associated with decrease in intracellular cholesterol efflux in dedifferentiated aortic smooth muscle cells. Biochim Biophys Acta. 1994; 1212: 235–244.[Medline] [Order article via Infotrieve]
77. Orlandi A, Francesconi A, Cocchia D, Corsini A, Spagnoli LG. Phenotypic heterogeneity influences apoptotic susceptibility to retinoic acid and cis-platinum of rat arterial smooth muscle cells in vitro: implications for the evolution of experimental intimal thickening. Arterioscler Thromb Vasc Biol. 2001; 21: 1118–1123.
78. Chan SW, Hegyi L, Scott S, Cary NR, Weissberg PL, Bennett MR. Sensitivity to Fas-mediated apoptosis is determined below receptor level in human vascular smooth muscle cells. Circ Res. 2000; 86: 1038–1046.
79. Kockx MM, Herman AG. Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc Res. 2000; 45: 736–746.
80. McCarthy NJ, Bennett MR. The regulation of vascular smooth muscle cell apoptosis. Cardiovasc Res. 2000; 45: 747–755.
81. Geng YJ, Libby P. Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb Vasc Biol. 2002; 22: 1370–1380.
82. Cremona O, Muda M, Appel RD, Frutiger S, Hughes GJ, Hochstrasser DF, Geinoz A, Gabbiani G. Differential protein expression in aortic smooth muscle cells cultured from newborn and aged rats. Exp Cell Res. 1995; 217: 280–287.[CrossRef][Medline] [Order article via Infotrieve]
83. Neuville P, Geinoz A, Benzonana G, Redard M, Gabbiani F, Ropraz P, Gabbiani G. Cellular retinol-binding protein-1 is expressed by distinct subsets of rat arterial smooth muscle cell in vitro and in vivo. Am J Pathol. 1997; 150: 509–521.[Abstract]
84. Bochaton-Piallat ML, Gabbiani F, Redard M, Desmouliere A, Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol. 1995; 146: 1059–1064.[Abstract]
85. Han DK, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol. 1995; 147: 267–277.[Abstract]
86. Perlman H, Maillard L, Krasinski K, Walsh K. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation. 1997; 95: 981–987.
87. Adams LD, Lemire JM, Schwartz SM. A systematic analysis of 40 random genes in cultured vascular smooth muscle subtypes reveals a heterogeneity of gene expression and identifies the tight junction gene zonula occludens 2 as a marker of epithelioid ‘pup’ smooth muscle cells and a participant in carotid neointimal formation. Arterioscler Thromb Vasc Biol. 1999; 19: 2600–2608.
88. Jahn L, Kreuzer J, von Hodenberg E, Kubler W, Franke WW, Allenberg J, Izumo S. Cytokeratins 8 and 18 in smooth muscle cells: detection in human coronary artery, peripheral vascular, and vein graft disease and in transplantation-associated arteriosclerosis. Arterioscler Thromb. 1993; 13: 1631–1639.
89. Giachelli C, Bae N, Lombardi D, Majesky M, Schwartz S. Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). Biochem Biophys Res Commun. 1991; 177: 867–873.[CrossRef][Medline] [Order article via Infotrieve]
90. Gadeau AP, Campan M, Millet D, Candresse T, Desgranges C. Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro. Arterioscler Thromb. 1993; 13: 120–125.
91. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest. 1993; 92: 1686–1696.
92. Shanahan CM, Weissberg PL, Metcalfe JC. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res. 1993; 73: 193–204.[Abstract]
93. Giachelli CM, Majesky MW, Schwartz SM. Developmentally regulated cytochrome P-450IA1 expression in cultured rat vascular smooth muscle cells. J Biol Chem. 1991; 266: 3981–3986.
94. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res. 1994; 74: 214–224.
95. Chaulet H, Desgranges C, Renault MA, Dupuch F, Ezan G, Peiretti F, Loirand G, Pacaud P, Gadeau AP. Extracellular nucleotides induce arterial smooth muscle cell migration via osteopontin. Circ Res. 2001; 89: 772–778.
96. Gadeau AP, Chaulet H, Daret D, Kockx M, Daniel-Lamaziere JM, Desgranges C. Time course of osteopontin, osteocalcin, and osteonectin accumulation and calcification after acute vessel wall injury. J Histochem Cytochem. 2001; 49: 79–86.
97. Hirota S, Imakita M, Kohri K, Ito A, Morii E, Adachi S, Kim HM, Kitamura Y, Yutani C, Nomura S. Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques: a possible association with calcification. Am J Pathol. 1993; 143: 1003–1008.[Abstract]
98. Fitzpatrick LA, Severson A, Edwards WD, Ingram RT. Diffuse calcification in human coronary arteries: association of osteopontin with atherosclerosis. J Clin Invest. 1994; 94: 1597–1604.
99. O’Brien ER, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Schwartz SM, Giachelli CM. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb. 1994; 14: 1648–1656.
100. Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, Schinke T, Karsenty G, Giachelli CM. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res. 2001; 89: 1147–1154.
101. Weiser-Evans MC, Schwartz PE, Grieshaber NA, Quinn BE, Grieshaber SS, Belknap JK, Mourani PM, Majack RA, Stenmark KR. Novel embryonic genes are preferentially expressed by autonomously replicating rat embryonic and neointimal smooth muscle cells. Circ Res. 2000; 87: 608–615.
102. Frid MG, Aldashev AA, Nemenoff RA, Higashito R, Westcott JY, Stenmark KR. Subendothelial cells from normal bovine arteries exhibit autonomous growth and constitutively activated intracellular signaling. Arterioscler Thromb Vasc Biol. 1999; 19: 2884–2893.
103. de Vries CJ, van Achterberg TA, Horrevoets AJ, ten Cate JW, Pannekoek H. Differential display identification of 40 genes with altered expression in activated human smooth muscle cells: local expression in atherosclerotic lesions of smags, smooth muscle activation-specific genes. J Biol Chem. 2000; 275: 23939–23947.
104. Blindt R, Vogt F, Lamby D, Zeiffer U, Krott N, Hilger-Eversheim K, Hanrath P, vom Dahl J, Bosserhoff AK. Characterization of differential gene expression in quiescent and invasive human arterial smooth muscle cells. J Vasc Res. 2002; 39: 340–352.[CrossRef][Medline] [Order article via Infotrieve]
105. Geary RL, Wong JM, Rossini A, Schwartz SM, Adams LD. Expression profiling identifies 147 genes contributing to a unique primate neointimal smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol. 2002; 22: 2010–2016.
106. Qin M, Zeng Z, Zheng J, Shah PK, Schwartz SM, Adams LD, Sharifi BG. Suppression subtractive hybridization identifies distinctive expression markers for coronary and internal mammary arteries. Arterioscler Thromb Vasc Biol. 2003; 23: 425–433.
107. Kohler A, Jostarndt-Fogen K, Rottner K, Alliegro MC, Draeger A. Intima-like smooth muscle cells: developmental link between endothelium and media? Anat Embryol (Berl). 1999; 200: 313–323.[CrossRef][Medline] [Order article via Infotrieve]
108. Nicosia RF, Villaschi S. Rat aortic smooth muscle cells become pericytes during angiogenesis in vitro. Lab Invest. 1995; 73: 658–666.[Medline] [Order article via Infotrieve]
109. van Royen N, Piek JJ, Buschmann I, Hoefer I, Voskuil M, Schaper W. Stimulation of arteriogenesis: a new concept for the treatment of arterial occlusive disease. Cardiovasc Res. 2001; 49: 543–553.
110. Verfaillie CM. Adult stem cells: assessing the case for pluripotency. Trends Cell Biol. 2002; 12: 502–508.[CrossRef][Medline] [Order article via Infotrieve]
111. Frid MG, Kale VA, Stenmark KR. Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circ Res. 2002; 90: 1189–1196.
112. Shimizu K, Sugiyama S, Aikawa M, Fukumoto Y, Rabkin E, Libby P, Mitchell RN. Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat Med. 2001; 7: 738–741.[CrossRef][Medline] [Order article via Infotrieve]
113. Religa P, Bojakowski K, Maksymowicz M, Bojakowska M, Sirsjo A, Gaciong Z, Olszewski W, Hedin U, Thyberg J. Smooth-muscle progenitor cells of bone marrow origin contribute to the development of neointimal thickenings in rat aortic allografts and injured rat carotid arteries. Transplantation. 2002; 74: 1310–1315.[Medline] [Order article via Infotrieve]
114. Campbell JH, Han CL, Campbell GR. Neointimal formation by circulating bone marrow cells. Ann N Y Acad Sci. 2001; 947: 18–24.[Medline] [Order article via Infotrieve]
115. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002; 8: 403–409.[CrossRef][Medline] [Order article via Infotrieve]
116. Karnovsky MJ, Wright TC Jr, Castellot JJ Jr, Choay J, Lormeau JC, Petitou M. Heparin, heparan sulfate, smooth muscle cells, and atherosclerosis. Ann N Y Acad Sci. 1989; 556: 268–281.[Medline] [Order article via Infotrieve]
117. Au YP, Kenagy RD, Clowes MM, Clowes AW. Mechanisms of inhibition by heparin of vascular smooth muscle cell proliferation and migration. Haemostasis. 1993; 23 (suppl 1): 177–182.
118. Orlandi A, Ropraz P, Gabbiani G. Proliferative activity and -smooth muscle actin expression in cultured rat aortic smooth muscle cells are differently modulated by transforming growth factor-ß1 and heparin. Exp Cell Res. 1994; 214: 528–536.[CrossRef][Medline]
[Order article via Infotrieve]
119. Neuville P, Yan Z, Gidlof A, Pepper MS, Hansson GK, Gabbiani G, Sirsjo A. Retinoic acid regulates arterial smooth muscle cell proliferation and phenotypic features in vivo and in vitro through an RAR-dependent signaling pathway. Arterioscler Thromb Vasc Biol. 1999; 19: 1430–1436.
120. Miano JM, Kelly LA, Artacho CA, Nuckolls TA, Piantedosi R, Blaner WS. All-trans-retinoic acid reduces neointimal formation and promotes favorable geometric remodeling of the rat carotid artery after balloon withdrawal injury. Circulation. 1998; 98: 1219–1227.
121. DeRose JJ Jr, Madigan J, Umana JP, Prystowsky JH, Nowygrod R, Oz MC, Todd GJ. Retinoic acid suppresses intimal hyperplasia and prevents vessel remodeling following arterial injury. Cardiovasc Surg. 1999; 7: 633–639.[CrossRef][Medline] [Order article via Infotrieve]
122. Yan ZQ, Sirsjo A, Bochaton-Piallat ML, Gabbiani G, Hansson GK. Augmented expression of inducible NO synthase in vascular smooth muscle cells during aging is associated with enhanced NF-B activation. Arterioscler Thromb Vasc Biol. 1999; 19: 2854–2862.
123. Peiro C, Redondo J, Rodriguez-Martinez MA, Angulo J, Marin J, Sanchez-Ferrer CF. Influence of endothelium on cultured vascular smooth muscle cell proliferation. Hypertension. 1995; 25: 748–751.
124. Nackman GB, Bech FR, Fillinger MF, Wagner RJ, Cronenwett JL. Endothelial cells modulate smooth muscle cell morphology by inhibition of transforming growth factor-ß1 activation. Surgery. 1996; 120: 418–425.[CrossRef][Medline] [Order article via Infotrieve]
125. Fillinger MF, Sampson LN, Cronenwett JL, Powell RJ, Wagner RJ. Coculture of endothelial cells and smooth muscle cells in bilayer and conditioned media models. J Surg Res. 1997; 67: 169–178.[CrossRef][Medline] [Order article via Infotrieve]
126. Vernon SM, Campos MJ, Haystead T, Thompson MM, DiCorleto PE, Owens GK. Endothelial cell-conditioned medium downregulates smooth muscle contractile protein expression. Am J Physiol. 1997; 272: C582–C591.
127. Petzelbauer E, Springhorn JP, Tucker AM, Madri JA. Role of plasminogen activator inhibitor in the reciprocal regulation of bovine aortic endothelial and smooth muscle cell migration by TGF-ß1. Am J Pathol. 1996; 149: 923–931.[Abstract]
128. Powell RJ, Bhargava J, Basson MD, Sumpio BE. Coculture conditions alter endothelial modulation of TGF-ß1 activation and smooth muscle growth morphology. Am J Physiol. 1998; 274: H642–H649.
This article has been cited by other articles:
 |
|
 |
|
  H. A. Madi, K. Riches, P. Warburton, D. J. O'Regan, N. A. Turner, and K. E. Porter Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and Type 2 diabetic patients Am J Physiol Cell Physiol, November 1, 2009; 297(5): C1307 - C1317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kogata, R. M. Tribe, R. Fassler, M. Way, and R. H. Adams Integrin-linked kinase controls vascular wall formation by negatively regulating Rho/ROCK-mediated vascular smooth muscle cell contraction Genes & Dev., October 1, 2009; 23(19): 2278 - 2283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Grabski, T. Shimizu, J. Deou, W. M. Mahoney Jr, M. A. Reidy, and G. Daum Sphingosine-1-Phosphate Receptor-2 Regulates Expression of Smooth Muscle Alpha-Actin After Arterial Injury Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1644 - 1650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Orlandi, A. Ferlosio, G. Arcuri, M. G. Scioli, S. De Falco, and L. G. Spagnoli Flt-1 expression influences apoptotic susceptibility of vascular smooth muscle cells through the NF-{kappa}B/IAP-1 pathway Cardiovasc Res, September 16, 2009; (2009) cvp288v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zhou, S. Negash, J. Liu, and J. U. Raj Modulation of pulmonary vascular smooth muscle cell phenotype in hypoxia: role of cGMP-dependent protein kinase and myocardin Am J Physiol Lung Cell Mol Physiol, May 1, 2009; 296(5): L780 - L789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Tharp, I. Masseau, J. Ivey, V. K. Ganjam, and D. K. Bowles Endogenous testosterone attenuates neointima formation after moderate coronary balloon injury in male swine Cardiovasc Res, April 1, 2009; 82(1): 152 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Morrow, S. Guha, C. Sweeney, Y. Birney, T. Walshe, C. O'Brien, D. Walls, E. M. Redmond, and P. A. Cahill Notch and Vascular Smooth Muscle Cell Phenotype Circ. Res., December 5, 2008; 103(12): 1370 - 1382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Berra-Romani, A. Mazzocco-Spezzia, M. V. Pulina, and V. A. Golovina Ca2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture Am J Physiol Cell Physiol, September 1, 2008; 295(3): C779 - C790. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Sanchez-Guerrero, V. C. Midgley, and L. M. Khachigian Angiotensin II induction of PDGF-C expression is mediated by AT1 receptor-dependent Egr-1 transactivation Nucleic Acids Res., April 1, 2008; 36(6): 1941 - 1951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Chadjichristos, S. Morel, J.-P. Derouette, E. Sutter, I. Roth, A. C. Brisset, M.-L. Bochaton-Piallat, and B. R. Kwak Targeting Connexin 43 Prevents Platelet-Derived Growth Factor-BB-Induced Phenotypic Change in Porcine Coronary Artery Smooth Muscle Cells Circ. Res., March 28, 2008; 102(6): 653 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-J. Liang, H. E. Ives, C.-M. Yang, and Y.-H. Ma 20-HETE inhibits the proliferation of vascular smooth muscle cells via transforming growth factor- J. Lipid Res., January 1, 2008; 49(1): 66 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tran, K. Ens-Blackie, E. S. Rector, G. L. Stelmack, K. D. McNeill, G. Tarone, W. T. Gerthoffer, H. Unruh, and A. J. Halayko Laminin-Binding Integrin {alpha}7 Is Required for Contractile Phenotype Expression by Human Airway Myocytes Am. J. Respir. Cell Mol. Biol., December 1, 2007; 37(6): 668 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Reddy, J. K. Vasir, G. V. Hegde, S. S. Joshi, and V. Labhasetwar Erythropoietin Induces Excessive Neointima Formation: A Study in a Rat Carotid Artery Model of Vascular Injury Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2007; 12(3): 237 - 247. [Abstract] [PDF]
|
|
|
|
|
|
P. Ocaya, A. C. Gidlof, P. S. Olofsson, H. Torma, and A. Sirsjo CYP26 Inhibitor R115866 Increases Retinoid Signaling in Intimal Smooth Muscle Cells Arterioscler Thromb Vasc Biol, July 1, 2007; 27(7): 1542 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhou, C. Dasgupta, S. Negash, and J. U. Raj Modulation of pulmonary vascular smooth muscle cell phenotype in hypoxia: role of cGMP-dependent protein kinase Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1459 - L1466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Hinz, S. H. Phan, V. J. Thannickal, A. Galli, M.-L. Bochaton-Piallat, and G. Gabbiani The Myofibroblast: One Function, Multiple Origins Am. J. Pathol., June 1, 2007; 170(6): 1807 - 1816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Brisset, H. Hao, E. Camenzind, M. Bacchetta, A. Geinoz, J.-C. Sanchez, C. Chaponnier, G. Gabbiani, and M.-L. Bochaton-Piallat Intimal Smooth Muscle Cells of Porcine and Human Coronary Artery Express S100A4, a Marker of the Rhomboid Phenotype In Vitro Circ. Res., April 13, 2007; 100(7): 1055 - 1062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Orlandi, A. Francesconi, M. Marcellini, A. Di Lascio, and L. G. Spagnoli Propionyl-L-carnitine Reduces Proliferation and Potentiates Bax-related Apoptosis of Aortic Intimal Smooth Muscle Cells by Modulating Nuclear Factor-{kappa}B Activity J. Biol. Chem., February 16, 2007; 282(7): 4932 - 4942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. Small, Z. Bolender, C. Bueno, C. O'Neil, Z. Nong, W. Rushlow, N. Rajakumar, C. Kandel, J. Strong, J. Madrenas, et al. Wilms' Tumor 1-Associating Protein Regulates the Proliferation of Vascular Smooth Muscle Cells Circ. Res., December 8, 2006; 99(12): 1338 - 1346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Vascular-wall remodeling of 3 human bypass vessels: organ culture and smooth muscle cell properties. J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 651 - 658.
|
|
|
|
|
|
J. Sainz, A. Al Haj Zen, G. Caligiuri, C. Demerens, D. Urbain, M. Lemitre, and A. Lafont Isolation of "Side Population" Progenitor Cells From Healthy Arteries of Adult Mice Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): 281 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. G. Egan, C. L. Wainwright, R. M. Wadsworth, and G. F. Nixon PDGF-induced signaling in proliferating and differentiated vascular smooth muscle: Effects of altered intracellular Ca2+ regulation Cardiovasc Res, August 1, 2005; 67(2): 308 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Stegemann, H. Hong, and R. M. Nerem Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype J Appl Physiol, June 1, 2005; 98(6): 2321 - 2327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Shen, S. P. Halenda, M. Sturek, and P. A. Wilden Novel Mitogenic Effect of Adenosine on Coronary Artery Smooth Muscle Cells: Role for the A1 Adenosine Receptor Circ. Res., May 13, 2005; 96(9): 982 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Volker, M. Besselmann, R. Dittrich, D. Nabavi, C. Konrad, R. Dziewas, S. Evers, S. Grewe, S. C. Kramer, R. Bachmann, et al. Generalized arteriopathy in patients with cervical artery dissection Neurology, May 10, 2005; 64(9): 1508 - 1513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yoshida and G. K. Owens Molecular Determinants of Vascular Smooth Muscle Cell Diversity Circ. Res., February 18, 2005; 96(3): 280 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Newby Dual Role of Matrix Metalloproteinases (Matrixins) in Intimal Thickening and Atherosclerotic Plaque Rupture Physiol Rev, January 1, 2005; 85(1): 1 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Wang, P. J. Rao, M. R. Castresana, and W. H. Newman TNF-{alpha} induces proliferation or apoptosis in human saphenous vein smooth muscle cells depending on phenotype Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H293 - H301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dobaczewski, S. Akrivakis, K. Nasser, L. H. Michael, M. L. Entman, and N. G. Frangogiannis Vascular Mural Cells in Healing Canine Myocardial Infarcts J. Histochem. Cytochem., August 1, 2004; 52(8): 1019 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Mulvihill, J. Jaeger, R. Sengupta, W. L. Ruzzo, C. Reimer, S. Lukito, and S. M. Schwartz Atherosclerotic Plaque Smooth Muscle Cells Have a Distinct Phenotype Arterioscler Thromb Vasc Biol, July 1, 2004; 24(7): 1283 - 1289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Gabbiani Control of Smooth Muscle Cell Activation Arterioscler Thromb Vasc Biol, May 1, 2004; 24(5): 804 - 805. [Full Text]
|
|
|
|
|
|
A. Khanna Concerted effect of transforming growth factor-{beta}, cyclin inhibitor p21, and c-myc on smooth muscle cell proliferation Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1133 - H1140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Gui and X.-L. Zheng Epidermal Growth Factor Induction of Phenotype-dependent Cell Cycle Arrest in Vascular Smooth Muscle Cells Is through the Mitogen-activated Protein Kinase Pathway J. Biol. Chem., December 26, 2003; 278(52): 53017 - 53025. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||